Close Menu

NEW YORK (GenomeWeb) – Medicare contractor Palmetto GBA issued several draft local coverage determinations in the last week, including positive coverage decisions for Myriad Genetics' EndoPredict test in breast cancer, CareDx's transplant test AlloSure, and an extension of coverage for Genomic Health's Oncotype DX prostate cancer test to include intermediate-risk patients.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.